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Abstract
Background
The optimal timing of intubation for critically ill patients with severe respiratory illness remains
controversial among healthcare providers. The coronavirus disease 2019 (COVID-19) pandemic has raised
even more questions about when to implement this life-saving therapy. While one group of providers prefers
early intubation for patients with respiratory distress because these patients may deteriorate rapidly without
it, other providers believe that intubation should be delayed or avoided because of its associated risks
including worse outcomes.

Research question
Our objective was to assess whether the timing of intubation in patients with severe COVID-19 pneumonia
was associated with differences in mortality or other outcomes.

Study design and methods
This was a single-center retrospective observational cohort study. We analyzed outcomes of patients who
were intubated secondary to COVID-19 pneumonia between March 13, 2020, and December 12, 2020, at
Henry Ford Hospital in Detroit, Michigan. Patients were categorized into two groups: early intubated
(intubated within 24 hours of the onset of severe respiratory distress) and late intubated (intubated after 24
hours of the onset of severe respiratory distress). Demographics, comorbidities, respiratory rate oxygenation
(ROX) index, sequential organ failure assessment (SOFA) score, and treatment received were compared
between groups. The primary outcome was mortality. Secondary outcomes were ventilation time, intensive
care unit stay, hospital length of stay, and discharge disposition. Post hoc and Kaplan-Meier survival
analyses were performed.

Results
A total of 110 patients were included: 55 early intubated and 55 late intubated. We did not observe a
significant difference in overall mortality between the early intubated (43%) and the late intubated groups
(53%) (p = 0.34). There was no statistically significant difference in patients' baseline characteristics
including SOFA scores (the early intubation group had a mean score of 7.5 compared to 6.7 in the late
intubation group). Based on the ROX index, the early intubation group had significantly more patients with a
reduced risk of intubation (45%) than the late group (27%) (p = 0.029). The early intubation group was treated
with a high-flow nasal cannula at a significantly lower rate (47%) than the late intubation group (83%) (p <
0.001). Significant differences in patient baseline characteristics, treatment received, and other outcomes
were not observed. Post hoc analysis adjusting for SOFA score between 0 and 9 revealed significantly higher
mortality in the late intubation group (49%) than in the early intubation group (26%) (p = 0.03). Patients in
the 0 to 9 SOFA group who were intubated later had 2.7 times the odds of dying during hospital admission
compared to patients who were intubated early (CI, 1.09-6.67).

Interpretation
The timing of intubation for patients with severe COVID-19 pneumonia was not significantly associated
with overall mortality or other patient outcomes. However, within the subgroup of patients with SOFA
scores of 9 or lower at the time of intubation, patients intubated after 24 hours of the onset of respiratory
distress had a higher risk of death than those who were intubated within 24 hours of respiratory distress.
Thus, patients with COVID-19 pneumonia who are not at a high level of organ dysfunction may benefit from
early mechanical ventilation.

Categories: Anesthesiology, Infectious Disease, Pulmonology
Keywords: kaplan-meier survival curves, sofa score, acute respiratory distress syndrome [ards], high flow nasal
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Introduction
At the end of 2019, a novel coronavirus was identified as the cause of a cluster of pneumonia cases in
Wuhan, China. It rapidly spread, resulting in a global pandemic. This disease has been designated
coronavirus disease 2019 (COVID-19) [1], and the virus that causes COVID-19 is severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). Around 5% of COVID-19 patients develop a critical form of the
disease and require intensive care unit (ICU) admission [2,3]. The main manifestation of severe COVID-19 is
acute hypoxemic respiratory failure requiring respiratory support, and the optimal supportive treatment for
this condition has not yet been established.
The need for mechanical ventilation among patients admitted to the ICU with COVID-19 and respiratory
failure varies widely (30-90%), and those patients who receive mechanical ventilation tend to have higher
mortality, ranging from 16% to 78% [3-6]. The initial recommendation of the Chinese Society of
Anesthesiology Task Force on Airway Management was to proceed with endotracheal intubation for patients
showing no improvement in respiratory distress after two hours of high-flow oxygen therapy or other
noninvasive support [7,8]. This recommendation was based on the observation that many patients
deteriorated precipitously and that they could be more safely intubated at an earlier stage, particularly given
the levels of hypoxemia encountered during intubation [7,8]. Few studies at the time had assessed the effect
of the timing of intubation and whether it would affect patient outcomes. One systematic review has looked
at intubation timing, and it defined early intubation as receiving mechanical ventilation within 24 hours of
ICU admission. The synthesized evidence suggested that the timing of intubation based on ICU admission
may have no effect on mortality or morbidity of critically ill patients with COVID-19 [9]. However, another
study, which included 54 patients, looked at the timing of intubation based on hospital admission, where
early intubation was defined as occurring between 4 and 24 hours from admission, while late intubation was
defined as intubation from day five to day 10 of admission [10]. They found a mortality benefit in the early
intubated group (10). Notably, none of the previous studies used the onset of respiratory distress as time
zero for patient enrollment.
The purpose of our study was to analyze the outcomes of patients with severe respiratory distress secondary
to COVID-19 pneumonia to see whether patients who received early intubation had different outcomes from
those who received late intubation. The primary outcome was mortality, and secondary outcomes were the
number of ventilator days, time spent in the ICU, hospital length of stay (LOS), and discharge disposition.
Because there are risks associated with delaying intubation, we hypothesized that patients who received
early mechanical ventilation would have lower mortality, morbidity, and hospital LOS than those who were
intubated later in their hospitalization.

Materials And Methods
We conducted a single-center retrospective chart review study. The population consisted of patients with
COVID-19 pneumonia confirmed with a positive polymerase chain reaction test that developed into severe
respiratory distress, who were admitted to the Henry Ford Hospital in Detroit, Michigan, a level 1 trauma
tertiary care center, between March 13, 2020, and December 12, 2020. We received approval from the
institutional review board at the Henry Ford Health System stating that this research was appropriate in
design and that it met the requirements of the Federal Guidelines, 45 CFR Part 46 and 21 CFR Part 50
(approval number 14370). Eligible patients were identified using the Henry Ford Health System EPIC
electronic medical record database. Patients included in the analysis had COVID-19 pneumonia with
bilateral infiltrates indicated by chest X-ray in addition to at least one of the following criteria: (1)
respiratory rate >30 for at least two hours and (2) oxygen saturation <93% for at least two hours. Patients
who had a “do not intubate” order at the time of enrollment were excluded from the analysis. The 110
eligible patient charts were divided into two groups: an early intubated group (intubated within 24 hours of
meeting inclusion criteria) and a late intubated group (intubated after 24 hours of meeting inclusion
criteria).
We looked at patient baseline characteristics, including age, body mass index (BMI, expressed as the ratio
kg/m2), history of diabetes mellitus, chronic obstructive pulmonary disease, chronic kidney disease,
ischemic heart disease, and sequential organ failure assessment (SOFA) score (at time of intubation). We
assessed the respiratory rate oxygenation (ROX) index as a measure of severity of respiratory distress at the
time of enrollment. We subsequently classified patients into low and high risk of intubation based on the
ROX index. We also evaluated the incidence of acute renal failure during hospitalization (defined per the
RIFLE [risk, injury, failure, loss of kidney function, and end-stage kidney disease] criteria, with either an
increase in creatinine that is three times the baseline or a creatinine level >4 mg/dL) and whether there was
a need for hemodialysis. We investigated whether patients were treated with steroids (prednisone,
methylprednisone, or dexamethasone), remdesivir, a high-flow nasal cannula (HFNC) prior to intubation,
muscle relaxants (cis-atracurium or rocuronium infusion) during mechanical ventilation, and the use of tidal
volume (TV) while on mechanical ventilation.
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The primary outcome was patient mortality. Secondary outcomes were ventilation days, days spent in the
ICU, hospital LOS, and discharge disposition. Discharge disposition categories were as follows: discharged
home to self-care (routine discharge), discharged home to care of organized home health service, discharge
to certified long-term care hospital, discharge to a skilled nursing facility, and other discharge.
We also looked into respiratory failure as the cause of death in both groups. Based on current evidence [11],
there are two classifications for pulmonary contribution to death. First, a severe pulmonary disease, defined
as “inability to liberate from mechanical ventilation, non-invasive ventilation, or heated high flow nasal
cannula due to inadequate oxygenation or ventilation without aforementioned support.” Another one is an
irreversible pulmonary disease, which is defined as “insupportable oxygenation or ventilation (defined as
PaO2 <40 mmHg on FIO2 1.0 for >2 h or respiratory acidosis with pH <7.1 on maximum ventilator settings) as
well as if care was withdrawn due to poor prognosis related to pulmonary organ system dysfunction.”
Numeric variables were summarized with mean and standard deviation (SD) or median and interquartile
range (IQR) and were compared using independent t-test or Mann-Whitney U tests. Categorical variables
were summarized with frequencies and proportions and were compared using the chi-square test or
Fisher's exact test. A post hoc comparison was conducted for patients with SOFA scores between 0 and 9. All
tests were two-tailed. Kaplan-Meier survival analysis was done to compare the long-term survival of
patients having a SOFA score equal to or less than 9 to those having a SOFA score greater than 9. Pairwise
comparisons within each SOFA score stratum were performed using the log-rank (Mantel-Cox) test. A pvalue <0.05 was considered statistically significant.

Results
Patient characteristics
A total of 110 patient charts were included in this analysis, including 55 patients who received early
intubation and 55 patients who received late intubation (Table 1). Apart from the ROX index, no statistically
significant differences in baseline characteristics were observed (Table 1). The mean age was 63.9 years (SD,
14.1) and the median BMI was 30.4 (IQR, 26.0-38.1), with no significant difference in either variable (age, p
= 0.762; BMI, p = 0.317). The early intubation group had a higher, but not significantly different, median
SOFA score (7.5; IQR 5-10) than the late intubation group (6.71; IQR, 5-8) (p = 0.057). The early intubation
group had a higher mean ROX index (5.4; SD, 3.4) than the late intubation group (4.4; SD, 2.5). Based on the
ROX index, 45% of patients in the early intubation group and 27% of patients in the late intubation group
were classified as having a reduced risk of intubation, and overall ROX index risks differed between groups (p
= 0.029) (Table 1).
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Variable

All (N = 110)

Early intubated (n = 55)

Late intubated (n = 55)

p-value

Age, year, mean (SD)

63.9 (14.1)

64.3 (12.7)

63.5 (15.5)

0.762

BMI, kg/m2 , median (IQR)

30.4 (26.0-38.1)

29.5 (24.4-38.8)

31.0 (27.1-37.5)

0.317

IHD, n (%)

10 (9.1)

5 (9.1)

5 (9.1)

1.000

Diabetes, n (%)

52 (51)

23 (48.9)

29 (52.7)

0.703

COPD, n (%)

20 (19.6)

11 (23.4)

9 (16.4)

0.372

Acute renal failure, n (%)

75 (68.2)

36 (65.5)

39 (70.9)

0.539

Dialysis, n (%)

35 (31.8)

17 (30.9)

18 (32.7)

0.838

CKD, n (%)

71 (69.6)

33 (70.2)

38 (69.1)

0.902

ROX score, mean (SD)

4.9 (3.0)

5.4 (3.4)

4.4 (2.5)

0.082

Risk of intubation, n (%)

0.029

Reduced risk

40 (36.4)

25 (45.5)

15 (27.3)

Intermediate risk

11 (10.0)

2 (3.6)

9 (16.4)

High risk

59 (53.6)

28 (50.9)

31 (56.4)

SOFA score, mean (IQR) [95% CI]

7.1 (5-9) [6.6-7.6]

7.5 (5-10) [6.7-8.3]

6.7 (5-8) [6.1-7.3]

0.057

TABLE 1: Baseline characteristics of patients who required mechanical ventilation secondary to
severe COVID-19.
BMI, body mass index; CI, confidence interval, CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; IHD, ischemic heart disease;
IQR, interquartile range; ROX, respiratory rate oxygenation index; SOFA, sequential organ failure assessment; SD, standard deviation.

Treatments for COVID-19
Steroids were given to the majority of patients (overall, 89%; early intubated, 90.9%; late intubated, 87.3%; p
= 0.54). Steroids were started when patients needed supplemental oxygen, and steroid treatment did not
change with intubation timing. Remdesivir was given to 31% of all patients, and there was no difference in
remdesivir use between the groups (early intubated, 25%; late intubated, 30%; p = 0.525). HFNC was used for
65% of all patients and was used significantly more in the late intubation group (early intubated, 47% versus
late intubated, 84%; p < 0.001) (Figure 1). A total of 45 patients received a muscle relaxant infusion while
being on mechanical ventilation, with 21 patients (38%) in the early intubation group receiving a muscle
relaxation infusion for a mean of 3.1 days (SD, 1.9) and 24 patients (44%) in the late intubation group
receiving a muscle relaxant infusion for a mean of 2.6 days (SD, 2.2) (Figure 1). There was no significant
difference in the use of muscle relaxants between the two groups (p = 0.228). No significant difference in the
use of TV was observed between groups. The early ventilation group had mean TV of 6.3 mL/kg of predicted
body weight (SD, 1.3), and the late ventilation group had a mean TV of 5.9 mL/kg of predicted body weight
(SD, 1.0) (p = 0.125).
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FIGURE 1: Treatments received by patients who required mechanical
ventilation secondary to severe COVID-19.
HFNC, high-flow nasal cannula.

Main outcomes
Of the 110 patients, 53 died (48%), including 24 (44%) patients who were intubated early and 29 (53%)
patients who were intubated late (p = 0.34); thus, overall mortality between the groups was not significantly
different. The median ventilation time for all patients was 12.5 days (IQR, 7-22), and median ventilation
time did not significantly differ between early intubated (14 days; IQR, 10-23) and late intubated patients
(10 days; IQR, 4.5-21; p = 0.084). The median number of days spent in the ICU for the entire cohort was 16
days (IQR, 10-23) (early intubated, 17 days; IQR, 11-26 vs. late intubated, 15 days; IQR, 11-27; p = 0.948).
The median hospital LOS for the group was 18.5 days (IQR, 13-29) (early intubated, 18 days; IQR, 11-30 vs.
late intubated, 19 days; IQR, 14-29; p = 0.428). Of the four patients who were discharged to home self-care
(7%), one patient (3.2%) had been intubated early and three patients (12%) had been intubated late (p =
0.297) (Table 2). As a cause of mortality due to pulmonary disease, our entire patients in both groups had
severe pulmonary disease criteria at the time of death. Regarding irreversible pulmonary disease, there was
no statistically significant difference in both groups where it contributed to a total of 19 out of 24 deaths
(79%) in the early intubation group and 19 out of 29 deaths (65%) in the late intubation group (p = 0.27).
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Outcome

All (N = 110)

Early intubated (n =
55)

Late intubated (n =
55)

pvalue

Mortality, n (%)

53 (48.2)

24 (43.6)

29 (52.7)

0.340

Ventilation time, median (IQR), days

12.5 (6.8-22.0)

14 (10-22.5)

10 (4.5-20.5)

0.084

ICU stay, median (IQR), days

16 (10.0-26.3)

17 (10.5-26)

15 (10.5-27)

0.948

Hospital LOS, median (IQR), days

18.5 (12.829.3)

18 (10.5-29.5)

19 (14-28.5)

0.428

Discharge disposition

0.297

Home under self-care, n (%)

4 (7.0)

1 (3.2)

3 (11.5)

16 (28.1)

8 (25.8)

8 (30.8)

Medicare-certified long-term care hospital, n (%)

11 (19.3)

5 (16.1)

6 (23.1)

Skilled nursing facility, n (%)

22 (38.6)

13 (41.9)

9 (34.6)

Other, n (%)

4 (7.0)

4 (12.9)

0 (0)

Home under the care of organized home health service org, n
(%)

TABLE 2: Primary and secondary outcomes of patients who received mechanical ventilation
secondary to severe COVID-19.
ICU, intensive care unit; IQR, interquartile range; LOS, length of stay.

Post hoc analysis of patients with SOFA scores between 0 and 9 and
multivariate analysis
Baseline Characteristics
Post hoc analysis showed that 89 patients had SOFA scores between 0 and 9 (38 in early intubation and 51 in
late intubation) (Table 3). Of these patients, median SOFA scores were 5.9 for the early intubation group
(IQR, 4.3-7.0) and 6.3 for the late intubation group (IQR, 5.0-7.0), with no significant difference between
groups (p = 0.14). ROX index within this patient subset did not differ significantly between groups, where
50% of patients in the early intubation group and 55% in the late intubation group were at high risk of
intubation (p = 0.059).
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Variable

Early intubated (n=38)

Late intubated (n=51)

p-value

Age, mean (SD), years

62.6 (12.8)

63.4 (15.9)

0.40

BMI, mean (SD) kg/m2

32.4 (9.7)

33.7 (9.4)

0.26

Acute renal failure, n (%)

22 (57.9)

37 (51.4)

0.15

Dialysis, n (%)

9 (24)

15 (29)

0.5

ROX index

0.059

Low risk for intubation n (%)

18 (47)

15 (29)

Intermediate risk for intubation n (%)

1 (3)

8 (16)

High risk for intubation n (%)

19 (50)

28 (55)

SOFA score median, (IQR) [95% CI]

5.9 (4-7) [5.7-6.6]

6.3 (5-7) [5.8-6.7]

0.14

TABLE 3: Post hoc analysis of patients with SOFA scores 0-9 (N = 89), baseline characteristics.
CI, confidence interval, IQR, interquartile range; ROX, respiratory rate oxygenation; SOFA, sequential organ failure assessment.

Outcomes
Mortality was significantly higher in patients who had been intubated late (49%) than in those who had been
intubated early (26%) (p = 0.03). While patients in the early intubation group were intubated for a slightly
longer time than those in the late intubation group (17 vs. 10 days; p = 0.055), the difference was not
significant. There were no significant differences between groups in any other secondary outcome (Table 4).
Lastly, multivariate analysis showed that patients in the late intubation group were approximately 2.7 times
(odds ratio) more likely to die compared to patients in the early intubation group (95% CI, 1.09-6.67) (Table
5). There was no statistically significant difference in the final cause of death in both groups, where 8 out of
10 patients (75%) in the early intubation group and 17 out of 25 patients (68%) in the late intubation group
died from irreversible pulmonary disease (p = 0.48).

Variable

Early intubated (n = 38)

Late intubated (n = 51)

p-value

Mortality, no. (%)

10 (26.3)

25 (49.0)

0.03

Ventilation time, median (IQR), days

17 (10-25)

10 (5-22)

0.055

ICU stay, median (IQR), days

19 (13-28)

17 (11-28)

0.438

Hospital LOS, median (IQR), days

23 (13-31)

19 (14-30)

0.826

Discharge disposition

0.272

Home under self-care, n (%)

1 (3.6)

3 (11.5)

Home under the care of organized home health service org, n (%)

8 (28.6)

8 (30.8)

Medicare-certified long-term care hospital, n (%)

4 (14.3)

6 (23.1)

Skilled nursing facility, n (%)

11 (39.3)

9 (34.6)

Other, n (%)

4 (14.3)

0 (0.0)

TABLE 4: Post hoc analysis of patients with SOFA scores 0-9 (N = 89), outcomes.
IQR, interquartile range; LOS, length of stay; SOFA, sequential organ failure assessment.
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Odds ratio (95% CI)
Early intubated

1.0 (Reference)

Late intubated

2.69 (1.09-6.67)

p-value

0.032

TABLE 5: Multivariate analysis of mortality.

Kaplan-Meier survival analysis
Figures 2, 3 show Kaplan-Meier survival analysis comparing patients with respiratory failure secondary to
COVID-19 who underwent early (blue, n = 55) versus late (green n = 55) intubation. Time to death was
measured from the time of hospital admission. Patients were stratified into two groups based on SOFA score
at the time of intubation: SOFA score 0-9 (Figure 2) and SOFA greater than 9 (Figure 3). Of the patients in the
early intubation group, 38 patients had a SOFA score of 0-9 and 17 patients had a SOFA score greater than 9.
Of the patients in the late intubation group, 51 patients had a SOFA score of 0-9 and only four patients had a
SOFA score greater than 9. Pairwise comparisons within each stratum showed that early intubation was
significantly associated with higher survivability (log-rank test, p = 0.028 for SOFA 0-9 and p = 0.039 for
SOFA >9).

FIGURE 2: Kaplan-Meier curve for patients with SOFA score 0-9.
Blue line = early intubation group and green line = late intubation group.
SOFA, sequential organ failure assessment.
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FIGURE 3: Kaplan-Meier curve for patients with SOFA score >9.
Blue line = early intubation group and green line = late intubation group.
SOFA, sequential organ failure assessment.

Discussion
In this study, we did not observe significant differences in overall mortality, ventilation days, ICU and
inpatient LOS, or discharge disposition between patients who were intubated early versus late for severe
pneumonia secondary to COVID-19. SOFA scores were slightly but not significantly higher in the patients
who were intubated early than in those who were intubated later. However, post hoc analysis of patients who
had SOFA scores between 0 and 9 showed that significantly more patients within this score range who were
intubated late died compared to those who were intubated early. Additionally, Kaplan-Meier survival
analysis stratified by SOFA score also showed that patients who were intubated later were more likely to die.
It is worth noting that a higher number of patients in the late intubation group were in SOFA scores between
0 and 9 and compared to 38 patients in the early intubation group. Apart from the use of HFNC, there were
no significant differences in the treatments received by each group, and HFNC had been used in the majority
of patients in the late intubation group. This may partially explain why intubation was delayed for these
patients, as the treatment team may have waited to see if the HFNC would be helpful.
Overall SOFA scores alone may not provide an adequate explanation for the difference we observed in
mortality between the intubation groups. The original SOFA study showed that critically ill patients (not
including COVID-19) with an initial SOFA score of 9 or lower had a mortality rate of less than 33%, while
patients with scores over 11 had a predicted mortality rate of 95% [12], indicating that higher scores are
associated with higher mortality. In our analyses, by stratifying patients based on SOFA scores, we saw that
the timing of intubation was associated with a mortality difference. For patients who had SOFA scores
indicating a potentially higher risk of mortality (>9), outcomes were predictably not favorable for either
intubation group, but patients who had been intubated later fared the worst. Interestingly, analysis of the
subset of patients in the 0 to 9 SOFA score group, which generally indicates a lower risk of mortality, still
showed that those patients who were intubated later were significantly more likely to die. We did not
appreciate any difference in baseline characteristics in the subset of patients with SOFA scores 0-9 to explain
this mortality difference apart from the ROX index. Even though our study did not show a statistically
significant difference in ROX index between groups, the early intubation group trended toward a higher
percentage of patients with a low risk of intubation compared to the late intubation group and both groups
had almost the same percentage of high risk for intubation. It is possible that the early intubation group may
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have had a larger percentage of patients with better respiratory reserve than the late intubation group, and
hence, could tolerate intubation with less risk of decompensation, including hypoxemia. Note that all of our
patients were treated in the same institution with similar guidelines for managing COVID-19, including
early proning and lung-protective ventilation and treatment protocols. This was evident in that the use of
TV during mechanical ventilation did not differ between groups as well as other treatments as steroids,
remdesivir, and muscle relaxant use. Our findings suggest that COVID-19 patients who do not exhibit
extreme organ dysfunction as indicated by SOFA score, and even those patients with ROX index indicating
low risk of intubation, still may benefit from mechanical ventilation soon after exhibiting severe respiratory
distress rather than later.
The question of when to use mechanical ventilation for patients with COVID-19 pneumonia is challenging,
and it is particularly complex in the early phase of illness when patients may have normal lung mechanics,
which could sway physicians away from choosing ventilation [13-15]. But intubating patients early may have
several benefits. First, there is evidence that patients with COVID-19 pneumonia have severe hypoxemia
with large TVs (14) that could lead to more patient self-inflicted lung injury [7,16-18]. Thus, experts have
argued that protective mechanical ventilation with effective sedation and paralysis should be implemented
early to prevent the subsequent risk of volutrauma and patient self-inflicted lung injury due to large
respiratory effort during noninvasive ventilatory support [14]. However, intubating COVID-19 patients may
take more time than what is required in a standard intubation setting, since time is needed for the intubation
team to assemble and don appropriate personal protective equipment and for transferring the patient to an
appropriate location while maintaining infection control measures. These delays due to complex procedures
could lead to a prolonged period of hypoxemia, and patients might subsequently deteriorate before receiving
mechanical ventilation, resulting in increased morbidity and mortality. Another potential advantage of
early intubation rather than using HFNC or noninvasive ventilation is that it can reduce the risk of viral
particle aerosolization and viral exposure of healthcare workers [5,19].
Notably, mechanical ventilation is not a risk-free treatment modality and is inherently associated with a
number of well-described complications such as ventilator-associated pneumonia [20], ventilator-induced
lung injury [21], hemodynamic disturbances [22], and issues related to sedation and immobilization [23].
Therefore, the decision to put COVID-19 patients on mechanical ventilation is not trivial, and more research
is needed so that we can improve guidelines for when to intubate patients with COVID-19 for optimal
outcomes.
Our study has several limitations. It is a retrospective chart review with a low patient population; therefore,
results may not be generalizable. Also, the decision to treat patients with mechanical ventilation was based
on physician discretion, and treatment guidelines for COVID-19 were in a state of flux during the study
period.

Conclusions
We observed no significant differences in overall mortality or other outcomes between patients with severe
COVID-19 who were intubated early after presenting with severe respiratory illness and those who were
intubated later. However, in the subset of patients who had lower SOFA scores at the time of intubation,
patients who were intubated after 24 hours of the onset of respiratory distress were more than two and a half
times more likely to die during hospitalization than patients who were intubated earlier.
Our findings suggest that patients with severe respiratory distress secondary to COVID-19 pneumonia who
do not have multi-organ failure may benefit from earlier treatment with mechanical ventilation rather than
non-invasive respiratory therapies. Larger, controlled studies, systematic reviews, or meta-analyses are
needed to elucidate the best timing strategy for treating patients who have severe COVID-19 with
mechanical ventilation.
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